Jaap Goudsmit

Grundare på

Leyden Laboratories B.V.

75 år

87 relationer

Health Technology

Health Services

Consumer Services

Profil

Jaap Goudsmit is the founder of Leyden Laboratories BV, founded in 2020, where the title held is Chief Scientific Officer.
Current jobs include Director-Emeritus at International AIDS Vaccine Initiative, Inc., Professor at Academisch Medisch Centrum since 1989, Member at New York University, and Professor at the University of Amsterdam since 1989.
Former jobs include Chairman at AIDS Foundation Houston, Inc., Chief Scientific Officer & Member-Management Board at Crucell NV from 2010 to 2012, and Senior Vice President at Vaccine Research International Plc from 2001 to 2002.
Education includes a doctorate from the University of Amsterdam.

Aktiva positioner av Jaap Goudsmit

Företag	Position	Start
University of Amsterdam University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University	Företagsledare/Principal	1989-01-01
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Företagsledare/Principal	-
Academisch Medisch Centrum Academisch Medisch Centrum Hospital/Nursing ManagementHealth Services Operates as a medical center and provides scientific research & education services for next generation of healthcare professionals	Företagsledare/Principal	1989-01-01
International AIDS Vaccine Initiative, Inc. International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS	Företagsledare/Principal	-
Leyden Laboratories B.V. Leyden Laboratories B.V. Pharmaceuticals: MajorHealth Technology Develops nasal sprays containing antibodies that target respiratory viruses	Grundare	2020-01-01

Alla aktiva positioner av Jaap Goudsmit

Tidigare kända positioner av Jaap Goudsmit

Företag	Position	Slut
Vaccine Research International Plc Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Working towards further clinical trials to examine the potential of vaccine SA75 to prevent staphylococcal infections in hospital patients and the wider community.	Företagsledare/Principal	2002-07-01
AIDS Foundation Houston, Inc. AIDS Foundation Houston, Inc. Hospital/Nursing ManagementHealth Services Provides housing and nursing care for the sick	Ordförande	-
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies	Teknisk/Vetenskaplig/F&U Direktör	-

Se detaljerna i Jaap Goudsmits erfarenhet

Jaap Goudsmits utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Jaap Goudsmits erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	8
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies	Health Technology
International AIDS Vaccine Initiative, Inc. International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS	Health Technology
Academisch Medisch Centrum Academisch Medisch Centrum Hospital/Nursing ManagementHealth Services Operates as a medical center and provides scientific research & education services for next generation of healthcare professionals	Health Services
AIDS Foundation Houston, Inc. AIDS Foundation Houston, Inc. Hospital/Nursing ManagementHealth Services Provides housing and nursing care for the sick	Health Services
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Amsterdam University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vaccine Research International Plc Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Working towards further clinical trials to examine the potential of vaccine SA75 to prevent staphylococcal infections in hospital patients and the wider community.	Commercial Services
Leyden Laboratories B.V. Leyden Laboratories B.V. Pharmaceuticals: MajorHealth Technology Develops nasal sprays containing antibodies that target respiratory viruses	Health Technology